Global BioAccess Fund
Overview
Global BioAccess Fund is a New York-based venture capital firm that invests in early-stage companies developing novel therapeutics and devices to address serious unmet medical needs in oncology, immunology, rare diseases, central nervous system disorders, and cardiology. The firm focuses on providing capital to support Investigational New Drug (IND) submissions and clinical trials, aiming to accelerate the development of innovative medical treatments. The fund's investment strategy centers on transformative technologies that can significantly impact patient care in its target therapeutic areas. By partnering with forward-thinking companies, Global BioAccess Fund seeks to advance the next generation of medicines. The firm has a history of co-investing with other prominent investors, such as Pfizer, Amgen, LG Corp., Lotte Holdings CVC, and Finchley H.V., to support its portfolio companies. Since its inception in 2021, Global BioAccess Fund has made several investments, including in companies like Nuvig Therapeutics, ShiraTronics, and Acesion Pharma. These investments reflect the firm's commitment to supporting innovative life sciences ventures that address critical health challenges. The fund's approach combines financial backing with strategic guidance to help portfolio companies navigate the complex landscape of medical product development.
Get the full list of 54,000+ investors
Global BioAccess Fund and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Global BioAccess Fund
What sectors does Global BioAccess Fund invest in?
Global BioAccess Fund invests in Healthcare, Pharmaceuticals, Medical Devices and Biotechnology, and is based in New York, United States. Global BioAccess Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does Global BioAccess Fund invest at?
Global BioAccess Fund backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 1M - 50M.
Which regions does Global BioAccess Fund invest in?
Global BioAccess Fund invests across United States.
Who are the partners at Global BioAccess Fund?
Team members listed for Global BioAccess Fund include Lisa Wisniewski (Managing Director) and Michael Krepps (Venture Partner).
How do I contact Global BioAccess Fund?
Global BioAccess Fund's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
